A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.

NCT02164955 · clinicaltrials.gov ↗
COMPLETED
Status
775
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celgene